• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD ZILVER PTX DRUG-ELUTING PERIPHERAL STENT; NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Catalog Number ZIV6-35-125-6.0-120-PTX
Device Problem Insufficient Information (3190)
Patient Problems Occlusion (1984); Claudication (2550); Surgical procedure, additional (2564)
Event Date 03/26/2014
Event Type  Injury  
Event Description
On (b)(6) 2012: two ziv6-35-125-6.0-120-ptx stents and one ziv6-35-125-7.0-60-ptx stent were placed in the left sfa of the patient.On (b)(6) 2014: "worsened claudication" was observed and diffused restenosis in all three zilver ptx stents was confirmed.Pta was conducted and the patient recovered.No further adverse effects to the patient have been reported as occurring as a result of this specific event.This report relates to one ziv6-35-125-6.0-120-ptx device of lot # c777375.Reference also related mdr reports # 3001845648-2014-00281 and 3001845648-2014-00283.
 
Manufacturer Narrative
(b)(4).This report relates to one ziv6-35-125-6.0-120-ptx device of lot # c777375.Reference also related mdr reports # 3001845648-2014-00281 and 3001845648-2014-00283.The zilver ptx device involved in this complaint was implanted in the patient and therefore is not available for evaluation.With the information provided, a document based investigation was carried out.It may be noted that re-stenosis is a common adverse event of endovascular procedures and can be caused by injury to the vessel (e.G.During pta and/or stenting.) vessel injury provokes an inflammatory response that leads (or amplifies) to the restenosis process.An additional comment from the physician was as follows: "it was usual restenosis." restenosis, worsen claudication of the stented artery are known potential adverse events associated with the placement of this device.A review of the manufacturing records revealed no discrepancies related to this complaint issue.Prior to distribution all zilver ptx devices are subject to visual inspection and functional checks to ensure device integrity.Since there are no images available for review, there is no evidence to suggest that re-stenosis did not occur; therefore the complaint is confirmed based on customer testimony.Due to the lack of images no other comments can be provided at this time.Quality engineering assessed the complaint and the risk has been determined to be low.Quality engineering will continue to monitor complaints of this nature for potential emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZILVER PTX DRUG-ELUTING PERIPHERAL STENT
Type of Device
NIU STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
COOK IRELAND LTD
limerick
EI 
Manufacturer Contact
sinead quaid, senior regulatory
EI  
61334440
MDR Report Key4314895
MDR Text Key18798607
Report Number3001845648-2014-00282
Device Sequence Number1
Product Code NIU
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P100022/S001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 10/29/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/25/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/04/2014
Device Catalogue NumberZIV6-35-125-6.0-120-PTX
Device Lot NumberC777375
Other Device ID Number(01)10827002513454(17)140504(1
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Distributor Facility Aware Date03/26/2014
Event Location Hospital
Date Manufacturer Received10/31/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/16/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age76 YR
-
-